重新考虑大型VSD的可操作性:透气性肺间歇指数 (DiPSI) 和一个概率观点.
Saurabh Kumar Gupta1, Shyam S Kothari1,2
1Department of Cardiology Cardiothoracic Centre, All India Institute of Medical Sciences New Delhi India.
Pulmonary circulation
|December 15, 2025
概括
一个新的指数 - - 扩张性肺突变指数 (DiPSI) - - 可能会改善心室隔膜缺陷 (VSD) 与肺动脉高血压 (PAH) 的可操作性评估. 与目前的肺血管抵抗指数 (PVRI) 单独相比,DiPSI提供了更细致的评估.
科学领域:
- 心脏病学 心脏病学
- 肺高血压是什么意思 肺高血压
- 儿科心脏手术 儿科心脏手术
背景情况:
- 在晚期出现的腹腔隔膜缺陷 (VSD) 与肺动脉高血压 (PAH) 中评估可操作性是具有挑战性的.
- 肺血管阻力指数 (PVRI) 是主要的指标,但有其局限性.
- 一些PVRI高的患者有良好的结果,而一些PVRI低的患者则会出现PAH复发.
研究的目的:
- 引入和评估透气性肺突变指数 (DiPSI) 作为PAH的VSD中可操作性评估的辅助工具.
- 与单独使用PVRI相比,提供更细致的评估.
主要方法:
- DiPSI被定义为透气性肺梯度 (DPG = PADP - PAWP) 分于Qp/Qs.
- 这种基于生理学的,经流量调整的指数旨在帮助复杂病例的临床判断.
主要成果:
- 迪普西提供了一个生理上接地,流量调整的指标.
- 它可能有助于澄清可操作性评估中的边界情况.
- 提供了比单独PVRI对PAH晚期VSD呈现者的更细微的评估.
结论:
- DiPSI是PVRI的宝贵补充,用于评估PAH晚出现VSD的可操作性.
- 这一指数可能会在复杂的儿科心脏病例中改善决策.
- 需要进一步验证以确认其临床效用.
相关概念视频
Mitral Stenosis III: Medical Management
220
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
220
Mitral Regurgitation III: Medical Management
253
Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
253
Aortic Regurgitation III: Medical Management
373
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
373
Aortic Regurgitation I: Introduction
429
IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
429
Mitral Regurgitation I: Introduction
371
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
371
Mitral Valve Prolapse II: Assessment and Management
380
IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...
380


